Foot rot, or infectious pododermatitis is a hoof infection that is commonly found in sheep, goat, and cattle. As the name suggests, it rots away the foot of the animal, more specifically the area between the two toes of the affected animal. It is extremely painful and contagious. It can be treated with a series of medications but if not treated the whole herd can become infected. The cause of the infection in cattle is two anaerobic bacteria(bacteria that can grow without oxygen), Fusobacterium necrophorum and Bacteroides m e laninogenicus. Both bacteria are common to the environment that cattle live in and Fusobacterium is present in the rumen and fecal matter of the cattle. Usually there is an injury to the skin between the hooves that allows the bacteria to infect the animal. Another cause of foot rot may be high temperatures or humidity causing the skin between the hooves to crack and let the bacteria infect the foot. This is one of the reasons that foot rot is such a major problem in the summer. Foot rot is easily identifiable by its appearance and foul odor. Treatment is usually with an antibiotic medication, and preventing injury to the feet is the best way to prevent foot rot.
·
[edit] Signs of Infection
The first sign of a foot rot infection is when the skin between the claws of the hoof begins to swell. Swelling usually appears twenty-four hours after infection. The skin between the toes may be very red and tender and the toes may separate because of all the swelling. This is very painful to the animal and can cause lameness. A crack can develop along the infected part and is yellow in color. The foot will have a foul odor. Another sign of infection is that the infected animal may lose a large amount of weight rapidly. It is critical to treat the problem immediately or the bones, tendons, and joints in the area can become infected which is much harder to treat. There is a condition known as super foot rot that is seen in some animals. Super foot rot is just like normal foot rot only infection occurs much faster and is usually much more severe. Most normal foot rot treatments will not cure this foot rot and a veterinarian should be contacted immediately.
[edit] Treatment
The best way to treat foot rot is to catch it as early as possible. The infected animals should be separated away from the herd as soon as possible to prevent the infection from spreading and allow the animal a better environment for healing. The first treatment is to clean the foot thoroughly and examine the foot to determine that it is definitely foot rot that is causing the infection. Keeping the wound clean and using an antibiotic ointment may help reduce the spread of infection. Foot rot is usually treated with an antimicrobial product. Penicillin, tetracycline, and other antibacterial medicines are often used to treat normal cases of foot rot. Usually the antimicrobial product is non-prescription but sometimes a veterinarian may choose to use a prescription medication. It is critical to closely monitor the animals to make sure they are responding to treatment. The infected animals should be kept dry until the healing has occurred. If the animal is showing no signs of recovery after three to four days the bacteria could have infected the other tissues of the foot and along with a veterinarian the owner should decide whether to amputate the bad foot or to put the animal down
(edit) Prevention
The infected animals can serve as the source of infection for the whole herd because they will spread the bacteria throughout the environment. The bacteriacan live without a host for one to ten months. Once another animal gets a cut or crack in the soft tissue between their toes the bacteria can infect the animal. This is why infected animals must be kept away from the rest. A good way to prevent foot rot is to keep any foreign objects that may cut or damage the foot out of the environment. This should be a practice regardless of whether a herd has foot rot or not. The cuts are what allow the bacteria to enter the foot tissue and cause the infection. Some cattle feeders add zincto the feed mixes and may vaccinate the animals for foot rot. Zinc is important to maintaining the skin and hooves of cattle. Cattle deficient in zinc will become infected easier than cattle with adequate zinc in their diet.
Clinical Signs and Diagnosis
The earliest and most obvious clinical sign of foot rot is lameness, which increases in severity as the disease progresses. Once the infectious organisms become established, they cause inflammation and necrosis of tissue, resulting in slight to severe swelling and pain. The swelling is usually more evident in the interdigital space and around the coronet (or skin horn junction). The swelling is usually sufficient to cause separation of the digits. A break or fissure in the interdigital space develops which may extend from the front of the foot to the bulbs of the heel. These lesions are sometimes difficult to see unless the foot is elevated and properly restrained for examination. The interdigital lesion is often necrotic along its edges and has a characteristic fetid or foul odor, hence the name foul-in-the-foot.
The signs of foot rot in cattle include lameness with holding or raising a foot, reluctance to move, impaired locomotion, loss of appetite, weight loss, low-grade fever and reduction in milk yield for lactating cows. Hind feet are affected most often and cattle tend to stand and walk on their toes. If left untreated, lameness becomes increasingly severe with infection extending to the distal and proximal interphalangeal joints and other deeper structures of the foot.
Diagnosis of foot rot is made by observation of the animal and physical examination of the foot for the characteristic gross lesions. Cattle producers often diagnose any lameness associated with foot swelling as foot rot, but a more careful examination may reveal other causes of the swelling and lameness.
Introduction
Ovine foot rot was first reported in 1869. It is an infectious, contagious disease of sheep that causes severe lameness and economic loss from decreased flock production. In a Virginia survey, approximately 21 percent of the producers considered foot rot to be a serious health problem in their flocks. With current understanding of the disease, and aided by drugs and vaccines, control and elimination of the disease should be the goal of all sheep producers.
Ovine foot rot is caused by an interaction of two anaerobic (without oxygen), Gram (-) bacteria, Bacteroides nodosus (formerly Fusiformis nodosus) and Fusobacterium necrophorum (formerly Sphaerophorus necrophorus). Fusobacterium necrophorum is a normal inhabitant of the ruminant digestive tract and in wet weather may interact with another bacteria, Corynebacterium pyogenes, to produce foot scald, an infection of the skin between the toes. This infection sets up the foot for invasion by Bacteroides nodosus, which, working in conjunction with the Fusobacterium, produces the condition referred to as foot rot. Since Bacteroides can only live in the hoof of an infected animal or in the soil for no more than 10-14 days, it is possible, through careful management procedures, to keep from introducing foot rot into a flock and to successfully control and/or eliminate the disease if the flock is infected. See Figure for a diagram of the predisposing factors for infection.
Return to Table of Contents
Diagnosis
Lameness is usually the major sign of an infected animal, although sheep with an early infection may not exhibit lameness. The area between the toes first becomes moist and reddened. Then the infection invades the sole of the hoof, undermining and causing separation of the horny tissues. The infection causes a characteristic foul odor and may infect one or more feet at the same time. Not all lame sheep have foot rot. Before undertaking an eradication, treatment, or control program, it is best to consult a veterinarian for a positive diagnosis and advice. Other diseases that may be confused with foot rot are foot abscesses, foot scald, laminitis or founder, corns, traumatic injuries, and foreign bodies lodged between the toes.
Return to Table of Contents
Transmission
The bacteria that causes foot rot, Bacteriodes nodosus, is spread from infected sheep to the ground, manure, bedding, etc., where it is then picked up by noninfected sheep. Foot rot is introduced by purchase of an infected animal or by simply using facilities or trucks that have been contaminated by infected sheep. Spread occurs best when temperatures are from 40-70 degrees F and the environment is wet. Since the organism doesn't survive long in the environment (< 2 wks), carriers in the flock will continue to reinfect the flock unless the animal is either culled or the organism is eliminated by proper treatment.
Return to Table of Contents
Prevention
It is always easier and less expensive to prevent foot rot than to treat it after it has become established. To remain disease free, there are five management principles that will help keep foot rot from being introduced into a clean flock.
1. Never buy sheep with foot rot or from a flock infected with foot rot, even if the animal(s) appear unaffected.
2. Avoid buying sheep at sale yards or livestock markets where clean and infected sheep may have been commingled or run through the same area.
3. Avoid using facilities (trails, corrals, dipping areas) where infected sheep may have been in the last two weeks.
4. Never transport sheep in a vehicle that has not been properly cleaned and disinfected.
5. Trim and treat the feet of all new arrivals, then re-examine them periodically during the 30-day isolation period.
Return to Table of Contents
Tuesday, February 19, 2008
A recent surve
(NewsTarget) A recent survey of 2,000 HIV and AIDS patients in Britain found that 69 percent were concerned with the long-term toxic side effects of HIV medications.
The survey, conducted by the UK Coalition of People Living with HIV and AIDS, also found that HIV patients were concerned about short-term drug side effects as well as the negative interactions of HIV drugs with other medications.
Edinburgh resident Nikk Bowden, who has been infected with AIDS for seven years, says he is concerned about what long-term use of HIV drugs could do to his body: "If you are expected to be on them for 30 to 40 years, as some doctors will tell you, what is going to happen further down the line?"
Bowden questions whether or not research on long-term side effects of the drugs is ongoing, or has been conducted at all. "It is a worry that you could be taking something that isn't fully understood over a period of time," Bowden says.
HIV drug side effects can include muscle pain and muscle wasting, pancreas and liver problems, nerve damage, fat redistribution and diabetes. Today, 40 million people worldwide are living with HIV/AIDS, and at the end of 2005, 1.3 million HIV-positive residents of poor countries had access to HIV drugs.
The survey, conducted by the UK Coalition of People Living with HIV and AIDS, also found that HIV patients were concerned about short-term drug side effects as well as the negative interactions of HIV drugs with other medications.
Edinburgh resident Nikk Bowden, who has been infected with AIDS for seven years, says he is concerned about what long-term use of HIV drugs could do to his body: "If you are expected to be on them for 30 to 40 years, as some doctors will tell you, what is going to happen further down the line?"
Bowden questions whether or not research on long-term side effects of the drugs is ongoing, or has been conducted at all. "It is a worry that you could be taking something that isn't fully understood over a period of time," Bowden says.
HIV drug side effects can include muscle pain and muscle wasting, pancreas and liver problems, nerve damage, fat redistribution and diabetes. Today, 40 million people worldwide are living with HIV/AIDS, and at the end of 2005, 1.3 million HIV-positive residents of poor countries had access to HIV drugs.
A newly redesigned
A newly redesigned antioxidant may play a critical role in preventing HIV-1-associated dementia, says a University of Missouri-Rolla chemist. Her research will be published in an upcoming issue of the journal Experimental Neurology.
“A third of the adults and half of the children with AIDS develop HIV-1-associated dementia,” explains Dr. Nuran Ercal, professor of chemistry at UMR and adjunct associate professor of internal medicine at Saint Louis University. “Cognitive impairment, postural disorders and tremors are among the most common symptoms encountered in patients suffering from AIDS dementia complex.”
Ercal collaborated with Dr. William Banks, professor of geriatric medicine at Saint Louis University, to determine whether the antioxidant N-acetylcysteine amide (NACA) could prevent cell death and reverse oxidative stress, a condition associated with many different irreversible neurological degeneration diseases, including Parkinson’s and Alzheimer’s.
“There’s a beautiful balance in our bodies,” Ercal says. “We have these free radicals -- atoms and molecules with an unpaired electron that attack other molecules. Our bodies have developed a natural antioxidant defense system that includes enzymes and small molecules to overcome harmful effects of these attacks. If the balance is tipped over, then we have oxidative stress.”
The researchers narrowed their study to the blood-brain barrier, a selective barrier that controls the entry of substances from the blood into the brain. They believed two toxic HIV proteins -- the envelope glycoprotein (gp120) and transregulatory protein (Tat) -- could be disrupting the protective barrier and allowing toxic materials to pass through to the brain. If true, the proteins could be inducing oxidative stress in the cells and causing dementia in patients.
Using an artificial model of a rat’s blood-brain barrier, the researchers incubated cells with the viral proteins for 24 hours. Every parameter the researchers then employed to measure oxidative stress described the same scenario: both gp120 and Tat were inducing oxidative stress in the rat brain capillaries.
In previous studies involving lead poisoning and radiation exposure, Ercal had successfully used the originally formulated N-acetylcysteine (NAC), the drug of choice in treating acetaminophen overdoses, to combat the resulting oxidative stress. Unlike NAC, the newly synthesized NACA passes easily through cell membranes, leading researchers to believe NACA could reverse the oxidative stress levels in the blood-brain barrier.
“We found NACA, this new compound, prevented cell death,” Ercal adds. “NACA returned all parameters to their control levels, and it’s not harmful except in extremely high concentrations. Therefore, we determined that while treating AIDS patients, perhaps we should include antioxidants to prevent oxidative stress or prevent possible dementia.”
The researchers are now studying the brain and liver samples from transgenic rats. The animals have been genetically modified to contain gp120, allowing the researchers to further study the effects of this protein.
“If gp120 is causing these free radicals, then we should have lots of free radicals in these animals because they are continuously making this protein,” Ercal adds
“A third of the adults and half of the children with AIDS develop HIV-1-associated dementia,” explains Dr. Nuran Ercal, professor of chemistry at UMR and adjunct associate professor of internal medicine at Saint Louis University. “Cognitive impairment, postural disorders and tremors are among the most common symptoms encountered in patients suffering from AIDS dementia complex.”
Ercal collaborated with Dr. William Banks, professor of geriatric medicine at Saint Louis University, to determine whether the antioxidant N-acetylcysteine amide (NACA) could prevent cell death and reverse oxidative stress, a condition associated with many different irreversible neurological degeneration diseases, including Parkinson’s and Alzheimer’s.
“There’s a beautiful balance in our bodies,” Ercal says. “We have these free radicals -- atoms and molecules with an unpaired electron that attack other molecules. Our bodies have developed a natural antioxidant defense system that includes enzymes and small molecules to overcome harmful effects of these attacks. If the balance is tipped over, then we have oxidative stress.”
The researchers narrowed their study to the blood-brain barrier, a selective barrier that controls the entry of substances from the blood into the brain. They believed two toxic HIV proteins -- the envelope glycoprotein (gp120) and transregulatory protein (Tat) -- could be disrupting the protective barrier and allowing toxic materials to pass through to the brain. If true, the proteins could be inducing oxidative stress in the cells and causing dementia in patients.
Using an artificial model of a rat’s blood-brain barrier, the researchers incubated cells with the viral proteins for 24 hours. Every parameter the researchers then employed to measure oxidative stress described the same scenario: both gp120 and Tat were inducing oxidative stress in the rat brain capillaries.
In previous studies involving lead poisoning and radiation exposure, Ercal had successfully used the originally formulated N-acetylcysteine (NAC), the drug of choice in treating acetaminophen overdoses, to combat the resulting oxidative stress. Unlike NAC, the newly synthesized NACA passes easily through cell membranes, leading researchers to believe NACA could reverse the oxidative stress levels in the blood-brain barrier.
“We found NACA, this new compound, prevented cell death,” Ercal adds. “NACA returned all parameters to their control levels, and it’s not harmful except in extremely high concentrations. Therefore, we determined that while treating AIDS patients, perhaps we should include antioxidants to prevent oxidative stress or prevent possible dementia.”
The researchers are now studying the brain and liver samples from transgenic rats. The animals have been genetically modified to contain gp120, allowing the researchers to further study the effects of this protein.
“If gp120 is causing these free radicals, then we should have lots of free radicals in these animals because they are continuously making this protein,” Ercal adds
The growing i
(NewsTarget) The growing impact of AIDS in Africa, Asia and Latin America has prompted the United Nations World Food Program to appeal to donor countries to fund food and nutrition for those afflicted.
At the XVI International AIDS Conference in Toronto, Robin Jackson, chief of the World Food Program (WFP) HIV/AIDS Service, said, "It is time to deliver more than drugs."
Although those with HIV/AIDS often list food as one of their most desperate needs, nutritional support for HIV programs is usually not touched upon during international HIV policy debates, Jackson said, which leaves the programs seriously under-funded.
"The prioritizing of AIDS drugs over basic nutrition has been a grievous distortion that deprives AIDS victims of what they need most," says Mike Adams, a holistic nutritionist. "What good are drugs when a person is suffering multiple nutritional deficiencies that suppress immune function in the first place? These people need real nutrition, not false hope from patented synthetic chemicals."
Estimates by the WFP state that roughly 1 million of the 6.4 million people expected to enroll in 2008 antiretroviral programs will need nutritional support at a cost of approximately 65 cents a day per patient. Jackson said that when AIDS develops, nutrition and food security become important partners in treatment.
Currently, HIV patients are usually only given rations for 6 months until they can get back on their feet, but Jackson cited a recent study found that malnourished patients exposed to antiretroviral therapy are six times more likely to die than well-nourished patients; possibly because malnutrition impairs people's ability to absorb the triple-drug therapy and renders them unable to benefit from it.
Poor nutrition may also heighten susceptibility to HIV-related diseases, and an undependable food supply can increase the likelihood of individuals adopting lifestyles that often lead to infection.
Tests for HIV have become cheaper and more obtainable for governments, but this has unfortunately lead to standalone HIV testing programs that the Human Rights Watch has criticized for being coercive, discriminatory, lacking in confidentiality and deficient in prevention information.
These programs -- such as the proposal before government in Punjab, India that would require people to get tested to receive or keep a driver's license -- criminalize HIV transmission, are often applied in an arbitrary manner and are impotent to slow the spread of HIV, the Human Rights Watch said.
At the XVI International AIDS Conference in Toronto, Robin Jackson, chief of the World Food Program (WFP) HIV/AIDS Service, said, "It is time to deliver more than drugs."
Although those with HIV/AIDS often list food as one of their most desperate needs, nutritional support for HIV programs is usually not touched upon during international HIV policy debates, Jackson said, which leaves the programs seriously under-funded.
"The prioritizing of AIDS drugs over basic nutrition has been a grievous distortion that deprives AIDS victims of what they need most," says Mike Adams, a holistic nutritionist. "What good are drugs when a person is suffering multiple nutritional deficiencies that suppress immune function in the first place? These people need real nutrition, not false hope from patented synthetic chemicals."
Estimates by the WFP state that roughly 1 million of the 6.4 million people expected to enroll in 2008 antiretroviral programs will need nutritional support at a cost of approximately 65 cents a day per patient. Jackson said that when AIDS develops, nutrition and food security become important partners in treatment.
Currently, HIV patients are usually only given rations for 6 months until they can get back on their feet, but Jackson cited a recent study found that malnourished patients exposed to antiretroviral therapy are six times more likely to die than well-nourished patients; possibly because malnutrition impairs people's ability to absorb the triple-drug therapy and renders them unable to benefit from it.
Poor nutrition may also heighten susceptibility to HIV-related diseases, and an undependable food supply can increase the likelihood of individuals adopting lifestyles that often lead to infection.
Tests for HIV have become cheaper and more obtainable for governments, but this has unfortunately lead to standalone HIV testing programs that the Human Rights Watch has criticized for being coercive, discriminatory, lacking in confidentiality and deficient in prevention information.
These programs -- such as the proposal before government in Punjab, India that would require people to get tested to receive or keep a driver's license -- criminalize HIV transmission, are often applied in an arbitrary manner and are impotent to slow the spread of HIV, the Human Rights Watch said.
If you have a long,
If you have a long, drawn-out, incurable but treatable disease, it's unfortunate for you but great for pharmaceutical companies. While you're suffering indefinitely, you're also buying expensive pharmaceutical drugs to make the disease "manageable."
"Managing" diseases is the trend in mainstream medicine, and it's the main message that pharmaceutical companies and the media market to consumers. "You have a mental disorder? That's okay. You can live a normal life, if you take these pills every day."
According to "AIDS: A Second Opinion" authors Gary Null and James Feast, the profits "stack up better" for pharmaceutical companies when people have to take treatments indefinitely for an incurable disease. HIV, for example, is a relative goldmine, since HIV-positive people have to take drug "cocktails" each day even before they develop symptomatic AIDS. Then, the profits add up even more after these people develop full-blown AIDS because they have to take drugs to treat opportunistic infections in addition to their regular drug cocktail.
Many people believe that pharmaceutical companies' hunger for profits triumphs over their desire to genuinely help the public, and that this blinded concern for profit above all has shaped -- and continues to shape -- mainstream medicine as we know it. The bottom line is simple: As Life Extension Magazine puts it, "Marketing issues frequently outweigh medical science in drug company decisions."
Modern medicine is a platform for profit, not health
This has implications that are more serious than one might initially think, especially considering the heavy role that pharmaceutical companies play in mainstream medicine. "Deep Healing" author Dr. Emmette Miller writes, "We have to remember that most medical research in this country is financed by pharmaceutical companies who are looking for new drugs they can produce and sell."
Now, things were not always this way. In his book, "Overdosed America," Dr. John Abramson describes the shift of medical research from the academic to the commercial sphere: "As the function of medical research in our society has been transformed from a fundamentally academic and scientific activity to a fundamentally commercial activity, the context in which the research is done has similarly changed: First in universities funded primarily by public sources, then in universities funded primarily by commercial sources, then by independent for-profit research organizations contracting directly with drug companies. And most recently, the three largest advertising agencies, Omnicom, Interpublic and WPP, have bought or invested in the for-profit companies that perform clinical trials." In my view, advertising agencies having financial ties to the companies that perform clinical trials – companies that are supposed to conduct objective research – is blatant conflict of interest; yet it's the basis of most mainstream medical research in the United States. In fact, according to Dr. Abramson, in the year 2000, only one-third of all medical research was performed in universities and academic medical centers.
Since, according to these and other sources, drug companies predominantly fund medical research, scientists have almost no choice but to mainly focus their time and effort on the most profitable, but not necessarily the most effective, treatments. Though an herb, which by its very nature cannot be patented, may treat and possibly even cure a disease, drug companies may nevertheless not fund research or marketing for it, leaving the general public largely ignorant of the herb's benefits. Mainstream medicine largely dismisses vitamins and minerals in the same manner as herbs.
Furthermore, research bias often continues into the doctor's office. As Gary Null writes in his Complete Guide to Health and Nutrition, "One report published in Fact magazine speculates that the principle reason vitamin C is not commonly prescribed is that it is not as profitable as those syrups and pills your doctor dispenses."
Stealing medicine from nature
However, this doesn't mean that pharmaceutical companies ignore plants and other natural medicines altogether; it's actually quite the opposite. According to Asian Health Secrets by Letha Hadady, approximately one-third of all pharmaceuticals are derived from plants' active ingredients. Though companies cannot patent natural plants in their whole form, they can patent plants' individual ingredients after a long, painstaking process of breaking down the plant into its components, isolating active ingredients and then claiming to have "discovered" these natural ingredients. However, this system, though profitable for drug companies, has a downside that Hadady reveals: "Many times the active ingredient does not work as well as the entire plant. According to tests done in Germany, Saint John's Wort, the entire herb, kills the AIDS virus in the test tube, while hypericum, the isolated active ingredient, does not." In other words, though the bottom line is simple, it means that this society is in a very dangerous predicament indeed.
This horrific state of modern medicine is a uniquely American phenomenon, according to "Innocent Casualties" author Elaine Feuer. She writes, "Because the U.S. is the only major industrialized nation that does not regulate the prices or profits of drug companies, prescription drugs generally cost 25 to 40 percent more than in other countries." In fact, drug companies rely on American sales for the bulk of their profits, even though many of their products are marketed worldwide, says "Natural Alternatives to Drugs" author Dr. Michael T. Murray.
Though this is bad for the average American consumer, it's great for pharmaceutical companies. According to Mike Fillon's book, "Ephedra Fact and Fiction," the global pharmaceutical market earned $364 billion in 2001, making it the world's most profitable stock market sector. Fillon writes that more than half of this revenue is from the United States alone, so although pharmaceuticals are more expensive for the American consumer, Americans still buy more prescription drugs than any other nation.
Hawking for Big Pharma
Now, at this point, you're probably wondering about the role the U.S. government plays in all this. In "Death by Prescription," Ray D. Strand writes, "The FDA is actually listening and catering to the industry's desires." According to Strand, the FDA facilitates the drug-approval process. Many people attribute the FDA's bias against herbs and other natural medicine to the agency's close "friendship" with the pharmaceutical industry, but it seems that they can't agree about the level of corruption. According to American Medical Publishing's book, "Prescription Medicines, Side Effects and Natural Alternatives," "The government is also part of the problem because it does not have the resources or the political will to do more about the dangers of prescription drugs. Also, powerful members of the American government, from the President on down, are all lobbied heavily by the cash rich drug companies."
In order for mainstream medicine to reach the level of effectiveness that it can and should attain, the inner workings of the medical community must change, starting with the pharmaceutical companies' hold on the government agencies that are supposed to protect American consumers. As Burton Goldberg writes in "Alternative Medicine," "To realize effective health care with cost reduction requires unlocking the strangulation hold of the pharmaceutical companies, the American Medical Association (AMA) and ... the FDA on all forms of fully effective, low-cost alternative, complementary, integrative, holistic medicine." Until then, mainstream medicine will remain the same, and that's the last thing American consumers need. It's time to put concern for public health, medicine and genuine science over corporate profits.
The experts speak on pharmaceutical companies and profits:
There is probably nothing more profitable to the drug companies than interminable treatment of patients with drugs that do not work. Yet countless patients, at great cost to our nation, are kept on these treatments because they have been proven to help two-thirds of people and health-care providers have no policies or procedures to do otherwise. When those who pay the bills realize how much of their money is being wasted, and how much can be saved by requiring policies and procedures to identify patients not helped by standard treatment and select alternatives for them, it may happen.
Alternative Medicine by Burton Goldberg, page 458
Diabetes is such a profitable business that physicians will put pre-diabetic patients, with only marginally high blood sugar, onto diabetes drugs before even trying weight loss and exercise.
Prescription Alternatives by Earl Mindell RPh PhD and Virginia Hopkins MA, page 403
With the growing epidemic of obesity, the drug companies can look forward to a financial windfall. Many millions of Americans will be taking their statin drugs to lower their cholesterol levels. And they could each be spending $3 a day, or $1100 a year, for the rest of their lives.
Health Care Meltdown by Robert H Lebow MD, page 229
Drug companies are profit-driven entities, so marketing issues weigh very heavily. Manufacturers feel great pressure to keep costs down while hastening new drugs to market. And drug companies aren't held responsible for the huge costs of dose-related side effects to the healthcare system. The result is that marketing issues frequently outweigh medical science in drug company decisions.
Disease Prevention And Treatment by Life Extension Foundation, page 723
We have to remember that most medical research in this country is financed by pharmaceutical companies who are looking for new drugs they can produce and sell. Psychoneuroimmunology research is aimed at showing that the body is capable of producing its own healing substances. The bottom line is that stockholders of the companies that invest in medical research can't see how they can profit from such research and so will naturally put their developmental money into the money-making ventures instead.
Deep Healing by Emmette Miller MD, page 138
As the function of medical research in our society has been transformed from a fundamentally academic and scientific activity to a fundamentally commercial activity, the context in which the research is done has similarly changed: first in universities funded primarily by public sources, then in universities funded primarily by commercial sources, then by independent for-profit research organizations contracting directly with drug companies. And most recently, the three largest advertising agencies, Omnicom, Interpublic, and WPP, have bought or invested in the for-profit companies that perform clinical trials.
Overdosed America by John Abramson MD, page 110
Moreover, if a drug company's profits increase because of slanted research, hasty marketing, and misleading advertising, other companies must adopt these same methods in order to remain competitive--and the race to the bottom accelerates. This is why in any area of endeavor, codes of behavior must be periodically reexamined. Doing so is a common occurrence in politics and sports, and it is what the drug companies must now undertake.
Overdose by Jay S Cohen, page 168
An independent research center could study other uses of new medications that were not studied by their manufacturers. It could research new uses or problems with generic drugs, which drug companies do not study because the patents of generic drugs have lapsed and there is little likelihood of profit.
Overdose by Jay S Cohen, page 175
In the United Sates, pharmaceutical companies support most medication research and development. Because they really can't earn a profit from natural substances, which they can't patent, they're reluctant to fund studies on plant estrogens. Fortunately, many medical centers are helping to bridge this research gap by establishing departments of complementary and alternative medicine. At the Rosenthal Center of Columbia University, for example, scientists are conducting studies of black cohosh and other phytoestrogens.
The Rhodiola Revolution by Richard P Brown MD and Patricia L Gerbarg MD, page 179
One of the reasons for this is economic. Herbs, by their very nature, cannot be patented. Because of this, drug companies cannot hold the exclusive right to sell a particular herb and they are not motivated to invest in testing or promoting herbs. The collection and preparation of herbal medicines cannot be as easily controlled as the manufacture of synthetic drugs, making profits less dependable.
Alternative Medicine by Burton Goldberg, page 252
The FDA estimates it costs over 7 million dollars to bring a new drug to market pharmaceutical companies put that figure closer to 70 million dollars. They say they need two million users of a substance just to break even. Since natural substances cannot be patented, there is even less room for profit in them.
Scientific Validation of Herbal Medicine by Daniel B Mowrey PhD, page 291
The pharmaceutical industry is, obviously, a very powerful force in American science, medicine, business, and politics. The industry must make large profits to realize a return on investment, particularly in a regulatory system where it costs $100 to $200 million dollars to bring a new drug to market.
Choices In Healing by Michael Lerner, page 613
While it is in the interest of such companies to find patentable cancer treatments, there is no corresponding incentive to develop non-patentable natural methods. Since it currently costs around $200 million to develop a new drug in the US, mainly to comply with Byzantine FDA regulations, the drug companies claim they must seek enormous profits from each and every drug.
Cancer Therapy by Ralph W Moss PhD, page 14
In order for pharmaceutical companies to earn a profit, they must develop drugs that are potent enough to patent and can be approved by the FDA. To gain FDA approval, these drugs must demonstrate an acceptable safety profile. However, the safe dose of potent drugs can vary considerably among individuals. What is safe for some people can be a lethal overdose for others. Yet doctors and drug companies usually recommend the same dose for everyone, even though lower doses of many prescription drugs can achieve the same beneficial effects, while dramatically reducing side effect risk and the cost of the medications.
Disease Prevention And Treatment by Life Extension Foundation, page 708
In addition, since niacin is a widely available generic agent, no pharmaceutical company stands to generate the huge profits that the other cholesterol-lowering drugs have enjoyed. As a result, niacin is not intensively advertised like the other drugs. Despite the advantages of niacin over the cholesterol-lowering drugs, niacin accounts for only 7.9 percent of all lipid-lowering prescriptions.
Encyclopedia Of Natural Medicine by Michael T Murray MD Joseph L Pizzorno ND, page 352
Unlike the standard treatments for heart disease, coconut oil is cheap, has no adverse side effects, and is readily available to everyone. Because it is a natural product that is already widely available, pharmaceutical and medical industries have no desire to fund studies or promote interest in this area. There is no profit for them. Since most of the information on MCFA and coconut oil are buried in scientific literature, few people are aware of the benefits. Knowledge about the true health aspects of coconut oil has to come from experienced clinicians, authors, and researchers who are familiar with the true facts about coconut oil. Yet they face an up-hill battle because they must fight prejudice and misguided popular opinion that is fueled by powerful profit-seeking enterprises.
Healing Miracles of Coconut Oil by Bruce Fife ND, page 85
By their very nature, prescription drugs are the perfect product for a monopoly. Drugs are patented and available from only one manufacturer, and prices can be increased at the discretion of the company with few consumer complaints. How many people who are ill question the cost of drugs prescribed by their doctor? During the 1980s, inflation rose 58 percent and pharmaceutical companies managed to triple their prices. In 1990 the drug industry was the most profitable industry in America, with 13.6 percent annual profits, more than triple the average Fortune 500 company. The 1991 median profit of a Fortune pharmaceutical company was $592 million. Because the U.S. is the only major industrialized nation that does not regulate the prices or profits of drug companies, prescription drugs generally cost 25 to 40 percent more than in other countries. For three out of four elderly Americans, prescription drugs are their biggest expense.
Innocent Casualties by Elaine Feuer, page 73
Drug costs are higher in the United States than anywhere else in the world. Most major industrial nations employ profit-control measures that limit how much a drug company can charge for a drug. Because most drug companies market the same drug throughout the world, they rely on American sales for the bulk of their profits.
Natural Alternatives To Drugs by Michael T Murray ND, page 23
The global pharmaceutical industry--which generated revenues of more than $364 billion in 2001--is the world's most profitable stock market sector. According to IMS Health, the leading drug industry market analyst, half the global drug sales are in the U.S. alone, with Europe and Japan accounting for another 37 percent.
"Managing" diseases is the trend in mainstream medicine, and it's the main message that pharmaceutical companies and the media market to consumers. "You have a mental disorder? That's okay. You can live a normal life, if you take these pills every day."
According to "AIDS: A Second Opinion" authors Gary Null and James Feast, the profits "stack up better" for pharmaceutical companies when people have to take treatments indefinitely for an incurable disease. HIV, for example, is a relative goldmine, since HIV-positive people have to take drug "cocktails" each day even before they develop symptomatic AIDS. Then, the profits add up even more after these people develop full-blown AIDS because they have to take drugs to treat opportunistic infections in addition to their regular drug cocktail.
Many people believe that pharmaceutical companies' hunger for profits triumphs over their desire to genuinely help the public, and that this blinded concern for profit above all has shaped -- and continues to shape -- mainstream medicine as we know it. The bottom line is simple: As Life Extension Magazine puts it, "Marketing issues frequently outweigh medical science in drug company decisions."
Modern medicine is a platform for profit, not health
This has implications that are more serious than one might initially think, especially considering the heavy role that pharmaceutical companies play in mainstream medicine. "Deep Healing" author Dr. Emmette Miller writes, "We have to remember that most medical research in this country is financed by pharmaceutical companies who are looking for new drugs they can produce and sell."
Now, things were not always this way. In his book, "Overdosed America," Dr. John Abramson describes the shift of medical research from the academic to the commercial sphere: "As the function of medical research in our society has been transformed from a fundamentally academic and scientific activity to a fundamentally commercial activity, the context in which the research is done has similarly changed: First in universities funded primarily by public sources, then in universities funded primarily by commercial sources, then by independent for-profit research organizations contracting directly with drug companies. And most recently, the three largest advertising agencies, Omnicom, Interpublic and WPP, have bought or invested in the for-profit companies that perform clinical trials." In my view, advertising agencies having financial ties to the companies that perform clinical trials – companies that are supposed to conduct objective research – is blatant conflict of interest; yet it's the basis of most mainstream medical research in the United States. In fact, according to Dr. Abramson, in the year 2000, only one-third of all medical research was performed in universities and academic medical centers.
Since, according to these and other sources, drug companies predominantly fund medical research, scientists have almost no choice but to mainly focus their time and effort on the most profitable, but not necessarily the most effective, treatments. Though an herb, which by its very nature cannot be patented, may treat and possibly even cure a disease, drug companies may nevertheless not fund research or marketing for it, leaving the general public largely ignorant of the herb's benefits. Mainstream medicine largely dismisses vitamins and minerals in the same manner as herbs.
Furthermore, research bias often continues into the doctor's office. As Gary Null writes in his Complete Guide to Health and Nutrition, "One report published in Fact magazine speculates that the principle reason vitamin C is not commonly prescribed is that it is not as profitable as those syrups and pills your doctor dispenses."
Stealing medicine from nature
However, this doesn't mean that pharmaceutical companies ignore plants and other natural medicines altogether; it's actually quite the opposite. According to Asian Health Secrets by Letha Hadady, approximately one-third of all pharmaceuticals are derived from plants' active ingredients. Though companies cannot patent natural plants in their whole form, they can patent plants' individual ingredients after a long, painstaking process of breaking down the plant into its components, isolating active ingredients and then claiming to have "discovered" these natural ingredients. However, this system, though profitable for drug companies, has a downside that Hadady reveals: "Many times the active ingredient does not work as well as the entire plant. According to tests done in Germany, Saint John's Wort, the entire herb, kills the AIDS virus in the test tube, while hypericum, the isolated active ingredient, does not." In other words, though the bottom line is simple, it means that this society is in a very dangerous predicament indeed.
This horrific state of modern medicine is a uniquely American phenomenon, according to "Innocent Casualties" author Elaine Feuer. She writes, "Because the U.S. is the only major industrialized nation that does not regulate the prices or profits of drug companies, prescription drugs generally cost 25 to 40 percent more than in other countries." In fact, drug companies rely on American sales for the bulk of their profits, even though many of their products are marketed worldwide, says "Natural Alternatives to Drugs" author Dr. Michael T. Murray.
Though this is bad for the average American consumer, it's great for pharmaceutical companies. According to Mike Fillon's book, "Ephedra Fact and Fiction," the global pharmaceutical market earned $364 billion in 2001, making it the world's most profitable stock market sector. Fillon writes that more than half of this revenue is from the United States alone, so although pharmaceuticals are more expensive for the American consumer, Americans still buy more prescription drugs than any other nation.
Hawking for Big Pharma
Now, at this point, you're probably wondering about the role the U.S. government plays in all this. In "Death by Prescription," Ray D. Strand writes, "The FDA is actually listening and catering to the industry's desires." According to Strand, the FDA facilitates the drug-approval process. Many people attribute the FDA's bias against herbs and other natural medicine to the agency's close "friendship" with the pharmaceutical industry, but it seems that they can't agree about the level of corruption. According to American Medical Publishing's book, "Prescription Medicines, Side Effects and Natural Alternatives," "The government is also part of the problem because it does not have the resources or the political will to do more about the dangers of prescription drugs. Also, powerful members of the American government, from the President on down, are all lobbied heavily by the cash rich drug companies."
In order for mainstream medicine to reach the level of effectiveness that it can and should attain, the inner workings of the medical community must change, starting with the pharmaceutical companies' hold on the government agencies that are supposed to protect American consumers. As Burton Goldberg writes in "Alternative Medicine," "To realize effective health care with cost reduction requires unlocking the strangulation hold of the pharmaceutical companies, the American Medical Association (AMA) and ... the FDA on all forms of fully effective, low-cost alternative, complementary, integrative, holistic medicine." Until then, mainstream medicine will remain the same, and that's the last thing American consumers need. It's time to put concern for public health, medicine and genuine science over corporate profits.
The experts speak on pharmaceutical companies and profits:
There is probably nothing more profitable to the drug companies than interminable treatment of patients with drugs that do not work. Yet countless patients, at great cost to our nation, are kept on these treatments because they have been proven to help two-thirds of people and health-care providers have no policies or procedures to do otherwise. When those who pay the bills realize how much of their money is being wasted, and how much can be saved by requiring policies and procedures to identify patients not helped by standard treatment and select alternatives for them, it may happen.
Alternative Medicine by Burton Goldberg, page 458
Diabetes is such a profitable business that physicians will put pre-diabetic patients, with only marginally high blood sugar, onto diabetes drugs before even trying weight loss and exercise.
Prescription Alternatives by Earl Mindell RPh PhD and Virginia Hopkins MA, page 403
With the growing epidemic of obesity, the drug companies can look forward to a financial windfall. Many millions of Americans will be taking their statin drugs to lower their cholesterol levels. And they could each be spending $3 a day, or $1100 a year, for the rest of their lives.
Health Care Meltdown by Robert H Lebow MD, page 229
Drug companies are profit-driven entities, so marketing issues weigh very heavily. Manufacturers feel great pressure to keep costs down while hastening new drugs to market. And drug companies aren't held responsible for the huge costs of dose-related side effects to the healthcare system. The result is that marketing issues frequently outweigh medical science in drug company decisions.
Disease Prevention And Treatment by Life Extension Foundation, page 723
We have to remember that most medical research in this country is financed by pharmaceutical companies who are looking for new drugs they can produce and sell. Psychoneuroimmunology research is aimed at showing that the body is capable of producing its own healing substances. The bottom line is that stockholders of the companies that invest in medical research can't see how they can profit from such research and so will naturally put their developmental money into the money-making ventures instead.
Deep Healing by Emmette Miller MD, page 138
As the function of medical research in our society has been transformed from a fundamentally academic and scientific activity to a fundamentally commercial activity, the context in which the research is done has similarly changed: first in universities funded primarily by public sources, then in universities funded primarily by commercial sources, then by independent for-profit research organizations contracting directly with drug companies. And most recently, the three largest advertising agencies, Omnicom, Interpublic, and WPP, have bought or invested in the for-profit companies that perform clinical trials.
Overdosed America by John Abramson MD, page 110
Moreover, if a drug company's profits increase because of slanted research, hasty marketing, and misleading advertising, other companies must adopt these same methods in order to remain competitive--and the race to the bottom accelerates. This is why in any area of endeavor, codes of behavior must be periodically reexamined. Doing so is a common occurrence in politics and sports, and it is what the drug companies must now undertake.
Overdose by Jay S Cohen, page 168
An independent research center could study other uses of new medications that were not studied by their manufacturers. It could research new uses or problems with generic drugs, which drug companies do not study because the patents of generic drugs have lapsed and there is little likelihood of profit.
Overdose by Jay S Cohen, page 175
In the United Sates, pharmaceutical companies support most medication research and development. Because they really can't earn a profit from natural substances, which they can't patent, they're reluctant to fund studies on plant estrogens. Fortunately, many medical centers are helping to bridge this research gap by establishing departments of complementary and alternative medicine. At the Rosenthal Center of Columbia University, for example, scientists are conducting studies of black cohosh and other phytoestrogens.
The Rhodiola Revolution by Richard P Brown MD and Patricia L Gerbarg MD, page 179
One of the reasons for this is economic. Herbs, by their very nature, cannot be patented. Because of this, drug companies cannot hold the exclusive right to sell a particular herb and they are not motivated to invest in testing or promoting herbs. The collection and preparation of herbal medicines cannot be as easily controlled as the manufacture of synthetic drugs, making profits less dependable.
Alternative Medicine by Burton Goldberg, page 252
The FDA estimates it costs over 7 million dollars to bring a new drug to market pharmaceutical companies put that figure closer to 70 million dollars. They say they need two million users of a substance just to break even. Since natural substances cannot be patented, there is even less room for profit in them.
Scientific Validation of Herbal Medicine by Daniel B Mowrey PhD, page 291
The pharmaceutical industry is, obviously, a very powerful force in American science, medicine, business, and politics. The industry must make large profits to realize a return on investment, particularly in a regulatory system where it costs $100 to $200 million dollars to bring a new drug to market.
Choices In Healing by Michael Lerner, page 613
While it is in the interest of such companies to find patentable cancer treatments, there is no corresponding incentive to develop non-patentable natural methods. Since it currently costs around $200 million to develop a new drug in the US, mainly to comply with Byzantine FDA regulations, the drug companies claim they must seek enormous profits from each and every drug.
Cancer Therapy by Ralph W Moss PhD, page 14
In order for pharmaceutical companies to earn a profit, they must develop drugs that are potent enough to patent and can be approved by the FDA. To gain FDA approval, these drugs must demonstrate an acceptable safety profile. However, the safe dose of potent drugs can vary considerably among individuals. What is safe for some people can be a lethal overdose for others. Yet doctors and drug companies usually recommend the same dose for everyone, even though lower doses of many prescription drugs can achieve the same beneficial effects, while dramatically reducing side effect risk and the cost of the medications.
Disease Prevention And Treatment by Life Extension Foundation, page 708
In addition, since niacin is a widely available generic agent, no pharmaceutical company stands to generate the huge profits that the other cholesterol-lowering drugs have enjoyed. As a result, niacin is not intensively advertised like the other drugs. Despite the advantages of niacin over the cholesterol-lowering drugs, niacin accounts for only 7.9 percent of all lipid-lowering prescriptions.
Encyclopedia Of Natural Medicine by Michael T Murray MD Joseph L Pizzorno ND, page 352
Unlike the standard treatments for heart disease, coconut oil is cheap, has no adverse side effects, and is readily available to everyone. Because it is a natural product that is already widely available, pharmaceutical and medical industries have no desire to fund studies or promote interest in this area. There is no profit for them. Since most of the information on MCFA and coconut oil are buried in scientific literature, few people are aware of the benefits. Knowledge about the true health aspects of coconut oil has to come from experienced clinicians, authors, and researchers who are familiar with the true facts about coconut oil. Yet they face an up-hill battle because they must fight prejudice and misguided popular opinion that is fueled by powerful profit-seeking enterprises.
Healing Miracles of Coconut Oil by Bruce Fife ND, page 85
By their very nature, prescription drugs are the perfect product for a monopoly. Drugs are patented and available from only one manufacturer, and prices can be increased at the discretion of the company with few consumer complaints. How many people who are ill question the cost of drugs prescribed by their doctor? During the 1980s, inflation rose 58 percent and pharmaceutical companies managed to triple their prices. In 1990 the drug industry was the most profitable industry in America, with 13.6 percent annual profits, more than triple the average Fortune 500 company. The 1991 median profit of a Fortune pharmaceutical company was $592 million. Because the U.S. is the only major industrialized nation that does not regulate the prices or profits of drug companies, prescription drugs generally cost 25 to 40 percent more than in other countries. For three out of four elderly Americans, prescription drugs are their biggest expense.
Innocent Casualties by Elaine Feuer, page 73
Drug costs are higher in the United States than anywhere else in the world. Most major industrial nations employ profit-control measures that limit how much a drug company can charge for a drug. Because most drug companies market the same drug throughout the world, they rely on American sales for the bulk of their profits.
Natural Alternatives To Drugs by Michael T Murray ND, page 23
The global pharmaceutical industry--which generated revenues of more than $364 billion in 2001--is the world's most profitable stock market sector. According to IMS Health, the leading drug industry market analyst, half the global drug sales are in the U.S. alone, with Europe and Japan accounting for another 37 percent.
hailand announced
hailand announced last week that because of rising prices of foreign-made HIV/AIDS drugs, it would issue a five-year license to manufacture an inexpensive generic version of Merck & Co.'s Efavirenz drug.
Though Merck -- which holds the patent on Efavirenz -- criticized the military Thai government's decision to make its own cheaper version of the anti-retroviral drug, health advocates and AIDS activists commended the Health Ministry.
"This is both a brave and a progressive step by the Royal Thai Government to place the interests of people living with HIV in Thailand front and center," said UNAIDS country coordinator Patrick Brenny.
The Thai government -- headed by the military after a September coup to oust former prime minister Thaksin Shinawatra -- declared a "national emergency" under World Trade Organization rules that allow governments to issue compulsory licenses to manufacture patented drugs without consent from the patent holder. Merck will receive a royalty of 0.5 percent on sales of its generic version of the drug, which will cost half what Merck charged for Efavirenz.
Thailand's national drug program, which treats 82,000 of the 580,000 HIV/AIDS patients in the country, has gained international recognition for its efficacy. However, as AIDS patients live longer and foreign drug companies boost prices, the government has struggled with costs.
Thawat Suntrajarn, head of the Health Ministry's Department of Disease Control, said foreign companies' prices are "very high, making it a big hurdle for patients to access [HIV/AIDS drugs] and the government cannot afford them. In the long run [patients] need this anti-retroviral drug to live a normal life like others."
Consumer health advocate Mike Adams, a vocal critic of intellectual property rights for pharmaceuticals, said more and more countries are beginning to question the patent protection pharmaceutical companies are granted for chemical compounds.
"When it comes to AIDS and public health, most people in the world believe that drugs should be open source and available to the public at non-monopolistic prices," Adams said. "But drug companies want to soak the population for as much money as they can, without consideration for whether people have AIDS, cancer or other diseases.
"They want to enforce profiteering prices on everyone, and they use the protection of intellectual property patents to get away with it," he said.
Merck claims it makes no profits off Efavirenz in Thailand, and that the Thai government did not contact the company to attempt to resolve the cost problems before issuing the generic production license.
According to a World Bank study of the Thai drug program, the government took a risk in overriding Merck's patent, as the decision could result in trade repercussions. However, supporters of the generic manufacturing license say the move could bolster Thailand's ability to negotiate lower prices with other drug firms.
###
Though Merck -- which holds the patent on Efavirenz -- criticized the military Thai government's decision to make its own cheaper version of the anti-retroviral drug, health advocates and AIDS activists commended the Health Ministry.
"This is both a brave and a progressive step by the Royal Thai Government to place the interests of people living with HIV in Thailand front and center," said UNAIDS country coordinator Patrick Brenny.
The Thai government -- headed by the military after a September coup to oust former prime minister Thaksin Shinawatra -- declared a "national emergency" under World Trade Organization rules that allow governments to issue compulsory licenses to manufacture patented drugs without consent from the patent holder. Merck will receive a royalty of 0.5 percent on sales of its generic version of the drug, which will cost half what Merck charged for Efavirenz.
Thailand's national drug program, which treats 82,000 of the 580,000 HIV/AIDS patients in the country, has gained international recognition for its efficacy. However, as AIDS patients live longer and foreign drug companies boost prices, the government has struggled with costs.
Thawat Suntrajarn, head of the Health Ministry's Department of Disease Control, said foreign companies' prices are "very high, making it a big hurdle for patients to access [HIV/AIDS drugs] and the government cannot afford them. In the long run [patients] need this anti-retroviral drug to live a normal life like others."
Consumer health advocate Mike Adams, a vocal critic of intellectual property rights for pharmaceuticals, said more and more countries are beginning to question the patent protection pharmaceutical companies are granted for chemical compounds.
"When it comes to AIDS and public health, most people in the world believe that drugs should be open source and available to the public at non-monopolistic prices," Adams said. "But drug companies want to soak the population for as much money as they can, without consideration for whether people have AIDS, cancer or other diseases.
"They want to enforce profiteering prices on everyone, and they use the protection of intellectual property patents to get away with it," he said.
Merck claims it makes no profits off Efavirenz in Thailand, and that the Thai government did not contact the company to attempt to resolve the cost problems before issuing the generic production license.
According to a World Bank study of the Thai drug program, the government took a risk in overriding Merck's patent, as the decision could result in trade repercussions. However, supporters of the generic manufacturing license say the move could bolster Thailand's ability to negotiate lower prices with other drug firms.
###
Targe The
(NewsTarget) There is often confusion surrounding the difference between two conditions known as diverticulosis and diverticulitis. I'm going to explain the difference and reveal how to treat the symptoms of diverticulitis naturally.
Diverticula are small, pea-sized, bulging pouches in the digestive tract. While diverticula can form anywhere, most occur in your large intestine and are many times found in people that experience frequent constipation.
Having diverticula in the intestines is known as diverticulosis. This condition is many times unrecognized by the person affected because diverticulosis seldom causes any problems. Every once in a while however, diverticula can become infected or inflamed. This condition is called diverticulitis.
Many experts believe that a low-fiber diet is a key contributor to diverticulitis. Reason being is lack of fiber in the diet can make stool sometimes harder to pass. The excess pressure can result in certain areas of the colon to become weakened and collapse. This results in marble-sized pouches (diverticula) protruding through the colon wall. These pouches, which are small at first, but become larger gradually; typically develop in the sigmoid and descending colon. These are the lower portions of your large intestine just above your rectum. They are often the result of straining during bowel movements over a number of years.
Sometimes stool can become lodged in one of the pouches and the result can be an infection. Small tears or perforations can also develop in an infected pouch, which can lead to an infection within your abdomen (peritonitis). A person may also develop a collection of pus called an abscess if the infection is limited to an area around the wall of your colon where the diverticula are inflamed.
Diverticulitis can be acute or chronic. The majority of people affected are usually between the ages of 50 and 90. One reason that older people are generally more affected is that the walls of the large intestine tend to weaken with age.
For many people, symptoms are non-existent or mistaken for simple indigestion. For those who do experience symptoms, a pain in the lower left side of the abdomen is common. The pain is typically severe and surfaces rather abruptly. However, sometimes a person can experience a mild pain that can worsen over several days and have a fluctuating intensity.
Other typical symptoms include abdominal tenderness, fever, nausea, and constipation or diarrhea.
Less common signs and symptoms of diverticulitis may include:
· Vomiting
· Bloating
· Frequent Urination
· Difficulty or pain while urinating
· Rectal Bleeding
· Tenderness in the abdomen
· Blood in the Stool
While the reason is not exactly known, there is some evidence that links smoking & stress to symptoms becoming worse. Other factors that increase risk of diverticulitis are disease in the genes, gallbladder disease, obesity & coronary artery disease.
The best steps you can take in treating diverticulitis have to do with your lifestyle.
A high fiber diet has been shown to be protective against diverticular disease. You'll need at least 20 to 35 grams of fiber a day to help prevent problems from diverticulosis. Consume fresh fruits and vegetables, cereals that are high in fiber and bran. Be sure to drink plenty of pure water each day, as a high fiber diet will not be effective without adequate water consumption.
Studies have also shown physical activity, specifically jogging or running, to protect against symptomatic diverticular disease.
Avoid foods such as celery and corn as these foods contain indigestible roughage and use bran to prevent constipation.
Eat a diet with your primary source of protein being from fish & vegetables. Stay away from grains, seeds or nuts, as these foods can be hard to digest which results in bloating & gas. Other foods that should be avoided include dairy products, red meat, fried foods, spices, sugar products as well as processed & refined foods.
Also remember to:
· Try not to strain during bowel movements
· Avoid alcohol
· Exercise moderately
· Drink at least eight glasses of pure water a day
· Avoid smoking
Establish a regular bowel routine by spending at least 10 minutes a day trying to have a bowel movement at approximately the same time.
Avoid extremely hot or cold foods and fluids (which cause gas).
When you feel an attack or pain coming on, give yourself a cleansing enema with 2 quarts of luke-warm water mixed with the juice from a fresh squeezed lemon. This will aid in ridding the colon of undigested food that has been trapped and will also relieve pain.
Aside from lifestyle changes, supplementing with the following can also be helpful:
Acidophilus (Take as directed on label) - Helps support a healthy intestinal tract (gut) and replaces the flora in the small intestine, primarily to improve assimilation.
Fiber (Take as directed on label) - Helps prevent constipation. Also prevents infection.
Super Greens Formula - Garden of Life provides an excellent greens formula that is high in chlorophyll, which is extremely beneficial for this condition. Diverticulosis sufferers also seem to do better when chlorella is part of the diet. Chlorella will provide you with all the benefits of magnesium, carotenoids, chlorophyll and much more.
Vitamin B Complex (100 mg 3 times daily) - Aids in proper digestion.
Proteolytic Enzymes (Take as directed on label, between meals) - Aids in digestion & reduces inflammation in the colon.
Essential Fatty Acids (Take as directed on label) - Aids in protecting the cells that line the wall of the colon.
L-Glutamine (500 mg twice daily. Take with water or juice but never with milk) - Maintains the absorption surfaces of the gut called the villi.
Vitamin C - Anti-inflammatory and boosts immunity. I recommend a minimum of 3,000 to 8,000 mg daily in divided doses.
Garlic - Aids in digestion and is a natural antibiotic. I personally use Kyolic Aged Garlic Extract by Wakunaga, which is a high-quality odorless organic supplement. Take 2 capsules 3 times daily.
Alfalfa (2,000 mg in capsules or tincture) - Natural source of vitamin K and essential minerals that most people with intestinal disorders are lacking. Also contains chlorophyll, which aids in healing.
Aloe Vera Juice (Drink ½ cup 3 times a day) - promotes healing of the inflamed areas.
Diverticula are small, pea-sized, bulging pouches in the digestive tract. While diverticula can form anywhere, most occur in your large intestine and are many times found in people that experience frequent constipation.
Having diverticula in the intestines is known as diverticulosis. This condition is many times unrecognized by the person affected because diverticulosis seldom causes any problems. Every once in a while however, diverticula can become infected or inflamed. This condition is called diverticulitis.
Many experts believe that a low-fiber diet is a key contributor to diverticulitis. Reason being is lack of fiber in the diet can make stool sometimes harder to pass. The excess pressure can result in certain areas of the colon to become weakened and collapse. This results in marble-sized pouches (diverticula) protruding through the colon wall. These pouches, which are small at first, but become larger gradually; typically develop in the sigmoid and descending colon. These are the lower portions of your large intestine just above your rectum. They are often the result of straining during bowel movements over a number of years.
Sometimes stool can become lodged in one of the pouches and the result can be an infection. Small tears or perforations can also develop in an infected pouch, which can lead to an infection within your abdomen (peritonitis). A person may also develop a collection of pus called an abscess if the infection is limited to an area around the wall of your colon where the diverticula are inflamed.
Diverticulitis can be acute or chronic. The majority of people affected are usually between the ages of 50 and 90. One reason that older people are generally more affected is that the walls of the large intestine tend to weaken with age.
For many people, symptoms are non-existent or mistaken for simple indigestion. For those who do experience symptoms, a pain in the lower left side of the abdomen is common. The pain is typically severe and surfaces rather abruptly. However, sometimes a person can experience a mild pain that can worsen over several days and have a fluctuating intensity.
Other typical symptoms include abdominal tenderness, fever, nausea, and constipation or diarrhea.
Less common signs and symptoms of diverticulitis may include:
· Vomiting
· Bloating
· Frequent Urination
· Difficulty or pain while urinating
· Rectal Bleeding
· Tenderness in the abdomen
· Blood in the Stool
While the reason is not exactly known, there is some evidence that links smoking & stress to symptoms becoming worse. Other factors that increase risk of diverticulitis are disease in the genes, gallbladder disease, obesity & coronary artery disease.
The best steps you can take in treating diverticulitis have to do with your lifestyle.
A high fiber diet has been shown to be protective against diverticular disease. You'll need at least 20 to 35 grams of fiber a day to help prevent problems from diverticulosis. Consume fresh fruits and vegetables, cereals that are high in fiber and bran. Be sure to drink plenty of pure water each day, as a high fiber diet will not be effective without adequate water consumption.
Studies have also shown physical activity, specifically jogging or running, to protect against symptomatic diverticular disease.
Avoid foods such as celery and corn as these foods contain indigestible roughage and use bran to prevent constipation.
Eat a diet with your primary source of protein being from fish & vegetables. Stay away from grains, seeds or nuts, as these foods can be hard to digest which results in bloating & gas. Other foods that should be avoided include dairy products, red meat, fried foods, spices, sugar products as well as processed & refined foods.
Also remember to:
· Try not to strain during bowel movements
· Avoid alcohol
· Exercise moderately
· Drink at least eight glasses of pure water a day
· Avoid smoking
Establish a regular bowel routine by spending at least 10 minutes a day trying to have a bowel movement at approximately the same time.
Avoid extremely hot or cold foods and fluids (which cause gas).
When you feel an attack or pain coming on, give yourself a cleansing enema with 2 quarts of luke-warm water mixed with the juice from a fresh squeezed lemon. This will aid in ridding the colon of undigested food that has been trapped and will also relieve pain.
Aside from lifestyle changes, supplementing with the following can also be helpful:
Acidophilus (Take as directed on label) - Helps support a healthy intestinal tract (gut) and replaces the flora in the small intestine, primarily to improve assimilation.
Fiber (Take as directed on label) - Helps prevent constipation. Also prevents infection.
Super Greens Formula - Garden of Life provides an excellent greens formula that is high in chlorophyll, which is extremely beneficial for this condition. Diverticulosis sufferers also seem to do better when chlorella is part of the diet. Chlorella will provide you with all the benefits of magnesium, carotenoids, chlorophyll and much more.
Vitamin B Complex (100 mg 3 times daily) - Aids in proper digestion.
Proteolytic Enzymes (Take as directed on label, between meals) - Aids in digestion & reduces inflammation in the colon.
Essential Fatty Acids (Take as directed on label) - Aids in protecting the cells that line the wall of the colon.
L-Glutamine (500 mg twice daily. Take with water or juice but never with milk) - Maintains the absorption surfaces of the gut called the villi.
Vitamin C - Anti-inflammatory and boosts immunity. I recommend a minimum of 3,000 to 8,000 mg daily in divided doses.
Garlic - Aids in digestion and is a natural antibiotic. I personally use Kyolic Aged Garlic Extract by Wakunaga, which is a high-quality odorless organic supplement. Take 2 capsules 3 times daily.
Alfalfa (2,000 mg in capsules or tincture) - Natural source of vitamin K and essential minerals that most people with intestinal disorders are lacking. Also contains chlorophyll, which aids in healing.
Aloe Vera Juice (Drink ½ cup 3 times a day) - promotes healing of the inflamed areas.
Subscribe to:
Comments (Atom)